ERBB2 and neoplasm: MDA-MB-231 tumour is one of the triple-negative breast cancer types lacking the most commonly targeted receptors (oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2/neu), which makes the targeted therapies inefficient34, 35.